Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ATORVASTATIN Cause Type iii immune complex mediated reaction? 9 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Type iii immune complex mediated reaction have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.0% of all adverse event reports for ATORVASTATIN.

9
Reports of Type iii immune complex mediated reaction with ATORVASTATIN
0.0%
of all ATORVASTATIN reports
0
Deaths
7
Hospitalizations

How Dangerous Is Type iii immune complex mediated reaction From ATORVASTATIN?

Of the 9 reports, 7 (77.8%) required hospitalization.

Is Type iii immune complex mediated reaction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does ATORVASTATIN Cause?

Type 2 diabetes mellitus (7,556) Myalgia (7,155) Drug hypersensitivity (3,929) Drug ineffective (3,865) Fatigue (3,439) Arthralgia (3,338) Rhabdomyolysis (3,286) Dyspnoea (3,137) Nausea (2,888) Asthenia (2,791)

What Other Drugs Cause Type iii immune complex mediated reaction?

RITUXIMAB (25) VANCOMYCIN (24) HUMAN IMMUNOGLOBULIN G (23) OXALIPLATIN (23) METHOTREXATE (19) MYCOPHENOLATE MOFETIL (18) TACROLIMUS (18) CYCLOPHOSPHAMIDE (17) BORTEZOMIB (16) CYCLOSPORINE (16)

Which ATORVASTATIN Alternatives Have Lower Type iii immune complex mediated reaction Risk?

ATORVASTATIN vs ATORVASTATIN\EZETIMIBE ATORVASTATIN vs ATOSIBAN ATORVASTATIN vs ATOVAQUONE ATORVASTATIN vs ATOVAQUONE\PROGUANIL ATORVASTATIN vs ATRACURIUM

Related Pages

ATORVASTATIN Full Profile All Type iii immune complex mediated reaction Reports All Drugs Causing Type iii immune complex mediated reaction ATORVASTATIN Demographics